Polyrizon Clears Key Safety Milestone for NASARIX Allergy Nasal Spray
Polyrizon Ltd. ( (PLRZ)) just unveiled an announcement. Polyrizon Ltd., a development-stage biotech firm specializing in intranasal hydrogel-based medical devices, is advancing proprietary nasal spray ...
ARS Pharmaceuticals Announces CEO Succession
Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.
Medical News Today
New daily GLP-1 pill for weight loss: How does it compare with Wegovy, Ozempic?
Share on Pinterest Could a new oral option help to meet the growing demand for GLP-1 medications? Image Credit: Medical News Today/Photo by Eli Lilly The Food and Drug Administration (FDA) has ...
Dermatology Advisor
Bemotrizinol: Exploring the Newly Approved Sunscreen Active Ingredient
Bemotrizinol, recently approved as a new active ingredient in sunscreens, is the first new ingredient for OTC sunscreen ...
The Healthy on MSN
Antihistamine Recall on 9,000 Bottles Gets Risk Level Update
The FDA is sharing emerging details on the nationwide withdrawal from market of a common allergy drug you could find in your ...
MPR
FDA to Review Oral Treatment for Obstructive Sleep Apnea
The FDA's acceptance of the NDA for AD109 marks a pivotal clinical milestone toward introducing the first oral pharmacotherapy designed to target the neuromuscular causes of obstructive sleep apnea.